The role of COX-2, successional prostaglandin E2 (PGE2) and its receptors have been investigated in many different tumor entities, such as colon, prostate, lung and breast cancers, as well as gynecological tumors, such as ovarian, cervical and endometrial cancers [7]. This evidence concerns the gene PTGS2 and neoplasm.